Literature DB >> 9056040

A review of management of benign paroxysmal positional vertigo by exercise therapy and by repositioning manoeuvres.

G J Beynon1.   

Abstract

Benign paroxysmal positional vertigo (BPPV) is a common condition that often resolves spontaneously, but can cause significant distress to a patient. Management of this condition includes no intervention, medication, surgery, physical exercises and more recently 'particle repositioning' manoeuvres. Repositioning manoeuvres aim to relocate free-floating particles from the posterior semicircular canal into the utricle where they will no longer cause vertiginous symptoms. This article describes the different exercises and repositioning manoeuvres in use and examines their efficacy. In the light of this review a management strategy for BPPV is suggested.

Entities:  

Mesh:

Year:  1997        PMID: 9056040     DOI: 10.3109/03005364000000005

Source DB:  PubMed          Journal:  Br J Audiol        ISSN: 0300-5364


  5 in total

1.  Calcium oxalate stone formation in the inner ear as a result of an Slc26a4 mutation.

Authors:  Amiel A Dror; Yael Politi; Hashem Shahin; Danielle R Lenz; Silvia Dossena; Charity Nofziger; Helmut Fuchs; Martin Hrabé de Angelis; Markus Paulmichl; Steve Weiner; Karen B Avraham
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

2.  An analysis of referral patterns for dizziness in the primary care setting.

Authors:  J C Bird; G J Beynon; A T Prevost; D M Baguley
Journal:  Br J Gen Pract       Date:  1998-12       Impact factor: 5.386

3.  The particle repositioning maneouvre for benign paroxysmal positioning vertigo.

Authors:  A Thakar; R C Deka
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2000-04

4.  Clinical evaluation of posterior canal benign paroxysmal positional vertigo.

Authors:  Titus S Ibekwe; C Rogers
Journal:  Niger Med J       Date:  2012-04

Review 5.  Vestibular rehabilitation in benign paroxysmal positional vertigo: Reality or fiction?

Authors:  Federica Bressi; Paola Vella; Manuele Casale; Antonio Moffa; Lorenzo Sabatino; Michele Antonio Lopez; Francesco Carinci; Rocco Papalia; Fabrizio Salvinelli; Silvia Sterzi
Journal:  Int J Immunopathol Pharmacol       Date:  2017-05-09       Impact factor: 3.219

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.